Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $970.03 | 67 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $156.87 | 14 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $133.57 | 9 | $0 (2019) |
| Novo Nordisk Inc | $73.24 | 5 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $67.09 | 4 | $0 (2019) |
| Amgen Inc. | $59.27 | 3 | $0 (2019) |
| PFIZER INC. | $57.33 | 5 | $0 (2018) |
| Allergan Inc. | $54.82 | 3 | $0 (2019) |
| Lilly USA, LLC | $54.48 | 3 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $46.77 | 3 | $0 (2017) |
| AbbVie, Inc. | $45.90 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $424.93 | 28 | Sunovion Pharmaceuticals Inc. ($113.10) |
| 2018 | $240.31 | 18 | PFIZER INC. ($44.85) |
| 2017 | $304.79 | 21 | Janssen Pharmaceuticals, Inc ($60.87) |
All Payment Transactions
67 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2019 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $11.25 | General |
| Category: Cardiovascular | ||||||
| 12/12/2019 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: RESPIRATORY | ||||||
| 12/10/2019 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: Diabetes | ||||||
| 11/19/2019 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: Diabetes | ||||||
| 11/05/2019 | Allergan Inc. | VIIBRYD (Drug) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2019 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: RESPIRATORY | ||||||
| 09/24/2019 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Diabetes | ||||||
| 09/12/2019 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $8.46 | General |
| Category: RESPIRATORY | ||||||
| 09/10/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: Diabetes | ||||||
| 09/03/2019 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $11.14 | General |
| Category: RESPIRATORY | ||||||
| 08/27/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/23/2019 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $11.16 | General |
| Category: RESPIRATORY | ||||||
| 08/13/2019 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: RESPIRATORY | ||||||
| 07/31/2019 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $6.00 | General |
| Category: RESPIRATORY | ||||||
| 07/30/2019 | Vanda Pharmaceuticals Inc. | Hetlioz (Drug) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: Non-24-Hour Sleep-Wake Disorder | ||||||
| 07/22/2019 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $7.75 | General |
| Category: RESPIRATORY | ||||||
| 07/16/2019 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: Diabetes | ||||||
| 07/02/2019 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: RESPIRATORY | ||||||
| 05/28/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: UROLOGY | ||||||
| 05/21/2019 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: Bone Health | ||||||
| 05/16/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/16/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/09/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/12/2019 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: Cardiology | ||||||
| 02/12/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 415 | 653 | $396,665 | $56,498 |
| 2022 | 9 | 456 | 814 | $460,062 | $62,686 |
| 2021 | 10 | 428 | 639 | $367,473 | $53,449 |
| 2020 | 11 | 492 | 668 | $372,471 | $58,930 |
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 134 | 297 | $174,822 | $26,938 | 15.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 117 | 124 | $76,725 | $10,774 | 14.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 67 | 68 | $77,441 | $8,858 | 11.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 66 | 133 | $54,719 | $8,019 | 14.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 31 | 31 | $12,958 | $1,909 | 14.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 122 | 305 | $171,534 | $23,778 | 13.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 81 | 193 | $75,670 | $10,453 | 13.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 88 | 93 | $55,194 | $7,446 | 13.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 48 | 48 | $52,149 | $7,235 | 13.9% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 33 | 34 | $34,348 | $4,626 | 13.5% |
| 99225 | Follow-up observation care per day, typically 25 minutes | Facility | 2022 | 11 | 67 | $26,331 | $3,620 | 13.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 14 | 14 | $20,676 | $2,315 | 11.2% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 38 | 38 | $15,344 | $2,066 | 13.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 21 | 22 | $8,816 | $1,147 | 13.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 91 | 188 | $100,989 | $14,965 | 14.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 83 | 188 | $70,014 | $10,352 | 14.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 65 | 66 | $68,306 | $10,086 | 14.8% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 42 | 42 | $40,050 | $5,745 | 14.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 64 | 68 | $38,416 | $5,572 | 14.5% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 14 | 14 | $19,544 | $2,370 | 12.1% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 30 | 30 | $11,446 | $1,667 | 14.6% |
| 99226 | Subsequent observation care, typically 35 minutes per day | Facility | 2021 | 14 | 15 | $8,109 | $1,194 | 14.7% |
| 99225 | Subsequent observation care, typically 25 minutes per day | Facility | 2021 | 11 | 14 | $5,274 | $775.04 | 14.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 14 | 14 | $5,325 | $722.54 | 13.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 91 | 179 | $91,049 | $14,747 | 16.2% |
About Dr. Hennie Abrio, MD
Dr. Hennie Abrio, MD is a Internal Medicine healthcare provider based in Roseburg, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/21/2009. The National Provider Identifier (NPI) number assigned to this provider is 1891925129.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hennie Abrio, MD has received a total of $970.03 in payments from pharmaceutical and medical device companies, with $424.93 received in 2019. These payments were reported across 67 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($970.03).
As a Medicare-enrolled provider, Abrio has provided services to 1,791 Medicare beneficiaries, totaling 2,774 services with total Medicare billing of $231,563. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Hospitalist
- Location Roseburg, OR
- Active Since 07/21/2009
- Last Updated 02/18/2015
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1891925129
Products in Payments
- LONHALA MAGNAIR (Drug) $141.23
- XARELTO (Drug) $92.71
- ENTRESTO (Drug) $67.09
- TRULICITY (Drug) $54.48
- SOLIQUA (Drug) $46.77
- Creon (Drug) $45.90
- INVOKANA (Drug) $40.86
- Repatha (Biological) $38.94
- NUEDEXTA (Drug) $34.61
- CHANTIX (Drug) $33.73
- Victoza (Drug) $30.73
- Tresiba (Drug) $28.64
- ELIQUIS (Drug) $26.45
- BYSTOLIC (Drug) $22.13
- Hetlioz (Drug) $21.39
- MYRBETRIQ (Drug) $20.78
- EVENITY (Biological) $20.33
- VIIBRYD (Drug) $20.29
- ANORO (Drug) $16.56
- Utibron (Drug) $15.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Roseburg
William Townsend, Md, MD
Internal Medicine — Payments: $3,059
Dr. Mohamed Abdel Khalek, M.d, M.D
Internal Medicine — Payments: $1,602
Lorrie Oksenholt, Do, DO
Internal Medicine — Payments: $1,576
Joel Lee, Md, MD
Internal Medicine — Payments: $1,275
Doru Totoian, Md, MD
Internal Medicine — Payments: $1,266
Dr. Mukesh Thawani, M.d, M.D
Internal Medicine — Payments: $834.34